SCHEMBL13448673

SCHEMBL13448673

COCCCn1ccc2ccc(CN(C(=O)C3CNCCO3)C3CC3)cc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ REN P00797 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2807382 1.00 REN (1.00) REN
SCHEMBL13131714 0.86 REN (0.76) REN
SCHEMBL2809394 0.86 REN (0.76) REN
SCHEMBL13131508 0.86 REN (0.76) REN
SCHEMBL13131554 0.85 REN (0.75) REN
SCHEMBL13131472 0.85 REN (0.75) REN
SCHEMBL13131542 0.85 REN (0.74) REN
SCHEMBL18508869 0.85 REN (0.73) REN
SCHEMBL13131578 0.85 REN (0.73) REN
SCHEMBL13131518 0.85 REN (0.79) REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2168952-B1 MORPHOLINE DERIVATIVES AS RENIN INHIBITORS MITSUBISHI TANABE PHARMA CORP (JP) 2017-02-15 — — EP disclosed
EP-2168952-A1 MORPHOLINE DERIVATIVE Mitsubishi Tanabe Pharma Corporation (JP) 2010-03-31 — — EP disclosed
Send feedback